Cargando...

An in vivo platform for identifying inhibitors of protein aggregation

Protein aggregation underlies an array of human diseases, yet only one small molecule therapeutic has been successfully developed to date. Here, we introduce an in vivo system, based on a β-lactamase tripartite fusion construct, capable of identifying aggregation-prone sequences in the periplasm of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nat Chem Biol
Autores principales: Saunders, Janet C., Young, Lydia M., Mahood, Rachel A., Jackson, Matthew P., Revill, Charlotte H., Foster, Richard J., Smith, D. Alastair, Ashcroft, Alison E., Brockwell, David J., Radford, Sheena E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4720988/
https://ncbi.nlm.nih.gov/pubmed/26656088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nchembio.1988
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!